Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 84 entries
Sorted by: Best Match Show Resources per page
Impact of previous cyst-enterostomy on patients' outcome following resection of bile duct cysts.

World journal of gastrointestinal surgery

Ouaissi M, Kianmanesh R, Ragot E, Belghiti J, Majno P, Nuzzo G, Dubois R, Revillon Y, Cherqui D, Azoulay D, Letoublon C, Pruvot FR, Paye F, Rat P, Boudjema K, Roux A, Mabrut JY, Gigot JF.
PMID: 27358675
World J Gastrointest Surg. 2016 Jun 27;8(6):427-35. doi: 10.4240/wjgs.v8.i6.427.

AIM: To analyze the impact of previous cyst-enterostomy of patients underwent congenital bile duct cysts (BDC) resection.METHODS: A multicenter European retrospective study between 1974 and 2011 were conducted by the French Surgical Association. Only Todani subtypes I and IVb...

Cite
Ouaissi M, Kianmanesh R, Ragot E, et al. Impact of previous cyst-enterostomy on patients' outcome following resection of bile duct cysts. World J Gastrointest Surg. 2016;8(6):427-35doi: 10.4240/wjgs.v8.i6.427.
Ouaissi, M., Kianmanesh, R., Ragot, E., Belghiti, J., Majno, P., Nuzzo, G., Dubois, R., Revillon, Y., Cherqui, D., Azoulay, D., Letoublon, C., Pruvot, F. R., Paye, F., Rat, P., Boudjema, K., Roux, A., Mabrut, J. Y., & Gigot, J. F. (2016). Impact of previous cyst-enterostomy on patients' outcome following resection of bile duct cysts. World journal of gastrointestinal surgery, 8(6), 427-35. https://doi.org/10.4240/wjgs.v8.i6.427
Ouaissi, Mehdi, et al. "Impact of previous cyst-enterostomy on patients' outcome following resection of bile duct cysts." World journal of gastrointestinal surgery vol. 8,6 (2016): 427-35. doi: https://doi.org/10.4240/wjgs.v8.i6.427
Ouaissi M, Kianmanesh R, Ragot E, Belghiti J, Majno P, Nuzzo G, Dubois R, Revillon Y, Cherqui D, Azoulay D, Letoublon C, Pruvot FR, Paye F, Rat P, Boudjema K, Roux A, Mabrut JY, Gigot JF. Impact of previous cyst-enterostomy on patients' outcome following resection of bile duct cysts. World J Gastrointest Surg. 2016 Jun 27;8(6):427-35. doi: 10.4240/wjgs.v8.i6.427. PMID: 27358675; PMCID: PMC4919710.
Copy Download .nbib Format: NLM
Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy.

World journal of hepatology

Dreyer C, Sablin MP, Bouattour M, Neuzillet C, Ronot M, Dokmak S, Belghiti J, Guedj N, Paradis V, Raymond E, Faivre S.
PMID: 25937868
World J Hepatol. 2015 Apr 28;7(6):910-5. doi: 10.4254/wjh.v7.i6.910.

Advanced cholangiocarcinoma is associated with poor prognostic survival and has limited therapeutic options available at present. The importance of angiogenesis and expression of pro-angiogenic factors in intrahepatic forms of cholangiocarcinoma suggest that therapies targeting angiogenesis might be useful for...

Cite
Dreyer C, Sablin MP, Bouattour M, et al. Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy. World J Hepatol. 2015;7(6):910-5doi: 10.4254/wjh.v7.i6.910.
Dreyer, C., Sablin, M. P., Bouattour, M., Neuzillet, C., Ronot, M., Dokmak, S., Belghiti, J., Guedj, N., Paradis, V., Raymond, E., & Faivre, S. (2015). Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy. World journal of hepatology, 7(6), 910-5. https://doi.org/10.4254/wjh.v7.i6.910
Dreyer, Chantal, et al. "Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy." World journal of hepatology vol. 7,6 (2015): 910-5. doi: https://doi.org/10.4254/wjh.v7.i6.910
Dreyer C, Sablin MP, Bouattour M, Neuzillet C, Ronot M, Dokmak S, Belghiti J, Guedj N, Paradis V, Raymond E, Faivre S. Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy. World J Hepatol. 2015 Apr 28;7(6):910-5. doi: 10.4254/wjh.v7.i6.910. PMID: 25937868; PMCID: PMC4411533.
Copy Download .nbib Format: NLM
Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours.

Clinical molecular pathology

Terris B, Fléjou JF, Dubois S, Ruszniewski P, Scoazec JY, Belghiti J, Potet F, Bernades P, Mignon M, Hénin D.
PMID: 16696075
Clin Mol Pathol. 1996 Aug;49(4):M203-8. doi: 10.1136/mp.49.4.m203.

Aims/background-To analyse the different isoforms of CD44 in various types of endocrine pancreatic and gut carcinoid tumours and to investigate the relation between their expression and tumour dissemination. This study was prompted by the recent observation that inappropriate splicing...

Cite
Terris B, Fléjou JF, Dubois S, et al. Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours. Clin Mol Pathol. 1996;49(4):M203-8doi: 10.1136/mp.49.4.m203.
Terris, B., Fléjou, J. F., Dubois, S., Ruszniewski, P., Scoazec, J. Y., Belghiti, J., Potet, F., Bernades, P., Mignon, M., & Hénin, D. (1996). Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours. Clinical molecular pathology, 49(4), M203-8. https://doi.org/10.1136/mp.49.4.m203
Terris, B, et al. "Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours." Clinical molecular pathology vol. 49,4 (1996): M203-8. doi: https://doi.org/10.1136/mp.49.4.m203
Terris B, Fléjou JF, Dubois S, Ruszniewski P, Scoazec JY, Belghiti J, Potet F, Bernades P, Mignon M, Hénin D. Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours. Clin Mol Pathol. 1996 Aug;49(4):M203-8. doi: 10.1136/mp.49.4.m203. PMID: 16696075; PMCID: PMC408059.
Copy Download .nbib Format: NLM
Surgical treatment of hepatocellular carcinoma.

HPB : the official journal of the International Hepato Pancreato Biliary Association

Belghiti J, Kianmanesh R.
PMID: 18333160
HPB (Oxford). 2005;7(1):42-9. doi: 10.1080/13651820410024067.

Surgery for hepatocellular carcinoma (HCC) includes partial liver resection (LR) and liver transplantation (LT). Although LT represents the most efficient treatment in patients with small HCC,

Cite
Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford). 2005;7(1):42-9doi: 10.1080/13651820410024067.
Belghiti, J., & Kianmanesh, R. (2005). Surgical treatment of hepatocellular carcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association, 7(1), 42-9. https://doi.org/10.1080/13651820410024067
Belghiti, Jacques, and Kianmanesh, Reza. "Surgical treatment of hepatocellular carcinoma." HPB : the official journal of the International Hepato Pancreato Biliary Association vol. 7,1 (2005): 42-9. doi: https://doi.org/10.1080/13651820410024067
Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford). 2005;7(1):42-9. doi: 10.1080/13651820410024067. PMID: 18333160; PMCID: PMC2023921.
Copy Download .nbib Format: NLM
Aqua-(5,10,15,20-tetra-phenyl-porphyrin-ato-κ(4) N)cadmium(II)-18-crown-6 (1/1).

Acta crystallographica. Section E, Structure reports online

Toumi H, Belghith Y, Daran JC, Nasri H.
PMID: 24046545
Acta Crystallogr Sect E Struct Rep Online. 2013 Jun 08;69:m354-5. doi: 10.1107/S160053681301489X. eCollection 2013.

The title compound, [Cd(C44H28N4)(H2O)]·(C12H24O6), was made by the reaction of the [Cd(TPP)] with an excess of 18-crown-6 in chloro-benzene (where TPP is tetra-phenyl-porphyrinate). The Cd(II) cation is chelated by a TPP anion and coordinated by a water mol-ecule in...

Cite
Toumi H, Belghith Y, Daran JC, et al. Aqua-(5,10,15,20-tetra-phenyl-porphyrin-ato-κ(4) N)cadmium(II)-18-crown-6 (1/1). Acta Crystallogr Sect E Struct Rep Online. 2013;69:m354-5doi: 10.1107/S160053681301489X.
Toumi, H., Belghith, Y., Daran, J. C., & Nasri, H. (2013). Aqua-(5,10,15,20-tetra-phenyl-porphyrin-ato-κ(4) N)cadmium(II)-18-crown-6 (1/1). Acta crystallographica. Section E, Structure reports online, 69m354-5. https://doi.org/10.1107/S160053681301489X
Toumi, Hamza, et al. "Aqua-(5,10,15,20-tetra-phenyl-porphyrin-ato-κ(4) N)cadmium(II)-18-crown-6 (1/1)." Acta crystallographica. Section E, Structure reports online vol. 69 (2013): m354-5. doi: https://doi.org/10.1107/S160053681301489X
Toumi H, Belghith Y, Daran JC, Nasri H. Aqua-(5,10,15,20-tetra-phenyl-porphyrin-ato-κ(4) N)cadmium(II)-18-crown-6 (1/1). Acta Crystallogr Sect E Struct Rep Online. 2013 Jun 08;69:m354-5. doi: 10.1107/S160053681301489X. eCollection 2013. PMID: 24046545; PMCID: PMC3772402.
Copy Download .nbib Format: NLM
A survey of .

Parasite epidemiology and control

Brik K, Hassouni T, Elkharrim K, Belghyti D.
PMID: 30847410
Parasite Epidemiol Control. 2019 Feb 12;4:e00094. doi: 10.1016/j.parepi.2019.e00094. eCollection 2019 Feb.

The study was designed to determine the prevalence of

Cite
Brik K, Hassouni T, Elkharrim K, et al. A survey of . Parasite Epidemiol Control. 2019;4:e00094doi: 10.1016/j.parepi.2019.e00094.
Brik, K., Hassouni, T., Elkharrim, K., & Belghyti, D. (2019). A survey of . Parasite epidemiology and control, 4e00094. https://doi.org/10.1016/j.parepi.2019.e00094
Brik, Kamal, et al. "A survey of ." Parasite epidemiology and control vol. 4 (2019): e00094. doi: https://doi.org/10.1016/j.parepi.2019.e00094
Brik K, Hassouni T, Elkharrim K, Belghyti D. A survey of . Parasite Epidemiol Control. 2019 Feb 12;4:e00094. doi: 10.1016/j.parepi.2019.e00094. eCollection 2019 Feb. PMID: 30847410; PMCID: PMC6378848.
Copy Download .nbib Format: NLM
Chemotherapy and its effect on liver hypertrophy: implications for portal vein embolization and resection.

Seminars in interventional radiology

Brouquet A, Belghiti J.
PMID: 21326557
Semin Intervent Radiol. 2008 Jun;25(2):162-7. doi: 10.1055/s-2008-1076682.

Liver resection remains the gold standard treatment for colorectal liver metastases (CRLM). The improvement of the efficacy of chemotherapy has resulted in an increase of CRLM candidates for curative resection, including a significant proposition of patients initially deemed unresectable....

Cite
Brouquet A, Belghiti J. Chemotherapy and its effect on liver hypertrophy: implications for portal vein embolization and resection. Semin Intervent Radiol. 2008;25(2):162-7doi: 10.1055/s-2008-1076682.
Brouquet, A., & Belghiti, J. (2008). Chemotherapy and its effect on liver hypertrophy: implications for portal vein embolization and resection. Seminars in interventional radiology, 25(2), 162-7. https://doi.org/10.1055/s-2008-1076682
Brouquet, Antoine, and Belghiti, Jacques. "Chemotherapy and its effect on liver hypertrophy: implications for portal vein embolization and resection." Seminars in interventional radiology vol. 25,2 (2008): 162-7. doi: https://doi.org/10.1055/s-2008-1076682
Brouquet A, Belghiti J. Chemotherapy and its effect on liver hypertrophy: implications for portal vein embolization and resection. Semin Intervent Radiol. 2008 Jun;25(2):162-7. doi: 10.1055/s-2008-1076682. PMID: 21326557; PMCID: PMC3036481.
Copy Download .nbib Format: NLM
Assessment of Sodium and Potassium Intakes in Children Aged 6 to 18 Years by 24 h Urinary Excretion in City of Rabat, Morocco.

Journal of nutrition and metabolism

Saeid N, Elmzibri M, Hamrani A, Latifa Q, Belghiti H, El Berri H, Benjeddou K, Bouziani A, Benkirane H, Taboz Y, Elhamdouchi A, El Kari K, Aguenaou H.
PMID: 30155290
J Nutr Metab. 2018 Aug 01;2018:8687192. doi: 10.1155/2018/8687192. eCollection 2018.

BACKGROUND: The incidence of noncommunicable diseases (NCDs) has greatly increased, mainly due to high level of dietary sodium. Thus, reduction of sodium intake in population has been recognized as one of the most cost-effective strategies to reduce NCDs. The...

Cite
Saeid N, Elmzibri M, Hamrani A, et al. Assessment of Sodium and Potassium Intakes in Children Aged 6 to 18 Years by 24 h Urinary Excretion in City of Rabat, Morocco. J Nutr Metab. 2018;2018:8687192doi: 10.1155/2018/8687192.
Saeid, N., Elmzibri, M., Hamrani, A., Latifa, Q., Belghiti, H., El Berri, H., Benjeddou, K., Bouziani, A., Benkirane, H., Taboz, Y., Elhamdouchi, A., El Kari, K., & Aguenaou, H. (2018). Assessment of Sodium and Potassium Intakes in Children Aged 6 to 18 Years by 24 h Urinary Excretion in City of Rabat, Morocco. Journal of nutrition and metabolism, 20188687192. https://doi.org/10.1155/2018/8687192
Saeid, Naima, et al. "Assessment of Sodium and Potassium Intakes in Children Aged 6 to 18 Years by 24 h Urinary Excretion in City of Rabat, Morocco." Journal of nutrition and metabolism vol. 2018 (2018): 8687192. doi: https://doi.org/10.1155/2018/8687192
Saeid N, Elmzibri M, Hamrani A, Latifa Q, Belghiti H, El Berri H, Benjeddou K, Bouziani A, Benkirane H, Taboz Y, Elhamdouchi A, El Kari K, Aguenaou H. Assessment of Sodium and Potassium Intakes in Children Aged 6 to 18 Years by 24 h Urinary Excretion in City of Rabat, Morocco. J Nutr Metab. 2018 Aug 01;2018:8687192. doi: 10.1155/2018/8687192. eCollection 2018. PMID: 30155290; PMCID: PMC6092998.
Copy Download .nbib Format: NLM
Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease.

Cytokine

Bahrini K, Belghith M, Maghrebi O, Bekir J, Kchaou M, Jeridi C, Amouri R, Hentati F, Belal S, Ben Sassi S, Barbouche MR.
PMID: 32151963
Cytokine. 2020 Mar 06;130:155054. doi: 10.1016/j.cyto.2020.155054. Epub 2020 Mar 06.

Treg-mediated immune suppression involves many molecular mechanisms including the cleavage of inflammatory extracellular ATP to adenosine by CD39 ectoenzyme. In the peripheral blood of Multiple Sclerosis (MS) patients, it has been suggested that CD39+ Treg cells have the potential...

Cite
Bahrini K, Belghith M, Maghrebi O, et al. Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease. Cytokine. 2020;130:155054doi: 10.1016/j.cyto.2020.155054.
Bahrini, K., Belghith, M., Maghrebi, O., Bekir, J., Kchaou, M., Jeridi, C., Amouri, R., Hentati, F., Belal, S., Ben Sassi, S., & Barbouche, M. R. (2020). Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease. Cytokine, 130155054. https://doi.org/10.1016/j.cyto.2020.155054
Bahrini, Khadija, et al. "Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease." Cytokine vol. 130 (2020): 155054. doi: https://doi.org/10.1016/j.cyto.2020.155054
Bahrini K, Belghith M, Maghrebi O, Bekir J, Kchaou M, Jeridi C, Amouri R, Hentati F, Belal S, Ben Sassi S, Barbouche MR. Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease. Cytokine. 2020 Mar 06;130:155054. doi: 10.1016/j.cyto.2020.155054. Epub 2020 Mar 06. PMID: 32151963.
Copy Download .nbib Format: NLM
How to perform a laparoscopic pelvic sentinel lymph node dissection using near-infrared fluorescence with indocyanine green in gynecological cancers.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Vésale E, Azaïs H, Belghiti J, Nikpayam M, Uzan C, Canlorbe G.
PMID: 30659031
Int J Gynecol Cancer. 2019 Feb;29(2):443. doi: 10.1136/ijgc-2018-000074. Epub 2019 Jan 18.

The role of pelvic sentinel lymph node dissection (SLND) is increasing in oncological pelvic surgery, especially in the management of cervical and endometrial cancer.SLND using indocyanine green (ICG) is safe and effective, and its sensitivity is higher than with...

Cite
Vésale E, Azaïs H, Belghiti J, et al. How to perform a laparoscopic pelvic sentinel lymph node dissection using near-infrared fluorescence with indocyanine green in gynecological cancers. Int J Gynecol Cancer. 2019;29(2):443doi: 10.1136/ijgc-2018-000074.
Vésale, E., Azaïs, H., Belghiti, J., Nikpayam, M., Uzan, C., & Canlorbe, G. (2019). How to perform a laparoscopic pelvic sentinel lymph node dissection using near-infrared fluorescence with indocyanine green in gynecological cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 29(2), 443. https://doi.org/10.1136/ijgc-2018-000074
Vésale, Elie, et al. "How to perform a laparoscopic pelvic sentinel lymph node dissection using near-infrared fluorescence with indocyanine green in gynecological cancers." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 29,2 (2019): 443. doi: https://doi.org/10.1136/ijgc-2018-000074
Vésale E, Azaïs H, Belghiti J, Nikpayam M, Uzan C, Canlorbe G. How to perform a laparoscopic pelvic sentinel lymph node dissection using near-infrared fluorescence with indocyanine green in gynecological cancers. Int J Gynecol Cancer. 2019 Feb;29(2):443. doi: 10.1136/ijgc-2018-000074. Epub 2019 Jan 18. PMID: 30659031.
Copy Download .nbib Format: NLM
Differential Gene Expression Patterns in Blood and Cerebrospinal Fluid of Multiple Sclerosis and Neuro-Behçet Disease.

Frontiers in genetics

Maghrebi O, Hanachi M, Bahrini K, Kchaou M, Jeridi C, Belal S, Ben Sassi S, Barbouche MR, Souiai O, Belghith M.
PMID: 33719347
Front Genet. 2021 Feb 26;12:638236. doi: 10.3389/fgene.2021.638236. eCollection 2021.

Inflammatory demyelinating disorders of the central nervous system are debilitating conditions of the young adult, here we focus on multiple sclerosis (MS) and neuro-Behçet disease (NBD). MS is an autoimmune disorder of the central nervous system. NBD, a neurological...

Cite
Maghrebi O, Hanachi M, Bahrini K, et al. Differential Gene Expression Patterns in Blood and Cerebrospinal Fluid of Multiple Sclerosis and Neuro-Behçet Disease. Front Genet. 2021;12:638236doi: 10.3389/fgene.2021.638236.
Maghrebi, O., Hanachi, M., Bahrini, K., Kchaou, M., Jeridi, C., Belal, S., Ben Sassi, S., Barbouche, M. R., Souiai, O., & Belghith, M. (2021). Differential Gene Expression Patterns in Blood and Cerebrospinal Fluid of Multiple Sclerosis and Neuro-Behçet Disease. Frontiers in genetics, 12638236. https://doi.org/10.3389/fgene.2021.638236
Maghrebi, Olfa, et al. "Differential Gene Expression Patterns in Blood and Cerebrospinal Fluid of Multiple Sclerosis and Neuro-Behçet Disease." Frontiers in genetics vol. 12 (2021): 638236. doi: https://doi.org/10.3389/fgene.2021.638236
Maghrebi O, Hanachi M, Bahrini K, Kchaou M, Jeridi C, Belal S, Ben Sassi S, Barbouche MR, Souiai O, Belghith M. Differential Gene Expression Patterns in Blood and Cerebrospinal Fluid of Multiple Sclerosis and Neuro-Behçet Disease. Front Genet. 2021 Feb 26;12:638236. doi: 10.3389/fgene.2021.638236. eCollection 2021. PMID: 33719347; PMCID: PMC7954360.
Copy Download .nbib Format: NLM
Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice.

JAMA ophthalmology

Proudfoot JA, Zangwill LM, Moghimi S, Bowd C, Saunders LJ, Hou H, Belghith A, Medeiros FA, Williams-Steppe E, Acera T, Dirkes K, Weinreb R.
PMID: 34110362
JAMA Ophthalmol. 2021 Aug 01;139(8):839-846. doi: 10.1001/jamaophthalmol.2021.1812.

IMPORTANCE: Clinical trials of glaucoma therapies focused on protecting the optic nerve have required large sample sizes and lengthy follow-up to detect clinically relevant change due to its slow rate of progression. Whether shorter trials may be possible with...

Cite
Proudfoot JA, Zangwill LM, Moghimi S, et al. Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice. JAMA Ophthalmol. 2021;139(8):839-846doi: 10.1001/jamaophthalmol.2021.1812.
Proudfoot, J. A., Zangwill, L. M., Moghimi, S., Bowd, C., Saunders, L. J., Hou, H., Belghith, A., Medeiros, F. A., Williams-Steppe, E., Acera, T., Dirkes, K., & Weinreb, R. (2021). Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice. JAMA ophthalmology, 139(8), 839-846. https://doi.org/10.1001/jamaophthalmol.2021.1812
Proudfoot, James A, et al. "Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice." JAMA ophthalmology vol. 139,8 (2021): 839-846. doi: https://doi.org/10.1001/jamaophthalmol.2021.1812
Proudfoot JA, Zangwill LM, Moghimi S, Bowd C, Saunders LJ, Hou H, Belghith A, Medeiros FA, Williams-Steppe E, Acera T, Dirkes K, Weinreb R. Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice. JAMA Ophthalmol. 2021 Aug 01;139(8):839-846. doi: 10.1001/jamaophthalmol.2021.1812. PMID: 34110362; PMCID: PMC8193543.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 84 entries